Joanna Iłzecka
Department of Neurological Rehabilitation
Medical University of Lublin
Lublin
Poland
Name/email consistency: high
- Serum soluble OX40 in patients with amyotrophic lateral sclerosis. Iłzecka, J. Acta. Clin. Croat (2012)
- Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis. Iłzecka, J. Acta Neurol. Scand. (2009)
- Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis. Iłzecka, J. Acta. Clin. Croat (2008)
- Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis. Iłzecka, J. Acta Neurol. Scand. (2008)
- Decreased serum endoglin level in patients with amyotrophic lateral sclerosis: a preliminary report. Iłzecka, J. Scand. J. Clin. Lab. Invest. (2008)
- Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis. Iłzecka, J. Scand. J. Clin. Lab. Invest. (2007)
- APRIL is increased in serum of patients with brain glioblastoma multiforme. Iłzecka, J., Iłzecki, M. Eur. Cytokine Netw. (2006)